|
Outcomes and toxicities in patients (pts) non-randomly assigned to immunotherapy Children’s Oncology Group (COG) ANBL0032. |
|
|
Stock and Other Ownership Interests - Pfizer |
Consulting or Advisory Role - Merck |
Research Funding - Jubilant DraxImage (Inst); Merck (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - GlaxoSmithKline |
|
|
Employment - PRA Health Sciences |
Consulting or Advisory Role - Partner Therapeutics |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Novartis |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Abbvie; Accelerated Medical Diagnostics; Amgen; Amgen (I); Anthem INC; Cardinal Health; Jazz Pharmaceuticals; Lilly; Merck; Novo Nordisk; Pfizer; Pfizer (I); Regeneron; Sanofi; Stryker; Stryker (I); United Therapeutics; United Therapeutics (I); Varex Imaging; Zimmer BioMet |
Research Funding - Merck (Inst); United Therapeutics (Inst) |
|
|
Consulting or Advisory Role - Auron Therapeutics; Illumina Radiopharmaceuticals |
Patents, Royalties, Other Intellectual Property - GPC2 binders and CARs (Inst); Neuroblastoma antigens (Inst) |
|
|
No Relationships to Disclose |
|
|
Patents, Royalties, Other Intellectual Property - I am an unpaid medical advisor to Invenra Inc. a monoclonal antibody biotech firm in Madison WI. My UW lab is collaborating with Invenra and receiving research reagents from them for mutual research. (Inst); I have partial interest in patents related to my work at the University of Wisconsin-Madison WI, that are held by and managed by the University of Wisconsin Foundation |
(OPTIONAL) Uncompensated Relationships - Invenra |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - OBI Pharma; OPKO Health/GeneDx |
|
Consulting or Advisory Role - OBI Pharma |
Speakers' Bureau - EUSA Pharma |
Research Funding - United Therapeutics (Inst) |
Patents, Royalties, Other Intellectual Property - cancer targeting peptides; Globo H-Diphtheria toxoid vaccine for cancer therapy; NKT stimulatory phenyl-glycolipids for cancer therapy and vaccine adjuvant |
Travel, Accommodations, Expenses - EUSA Pharma |